Table 2.
POSITIVE CHANGES | |
Medication Take
Homes and Deliveries |
Most participants found increased medication take home doses and newly initiated deliveries to be a favorable change • Found less in-person MOUD program contact to be a positive change • Allowed for a better life balance |
Telehealth | Most participants found telehealth to be a favorable change • Found less in-person MOUD program contact to be a positive change • Allowed for providers to reach underserved communities in rural and other difficult locations |
CHALLENGES | |
Medication Take
Homes and Deliveries |
A few participants noted decreased access to basic goods that they were able to previously obtain via in-person visits at some MOUD clinics |
Telehealth | A few participants noted decreased access to basic goods that they were able to previously obtain via in-person visits at some MOUD clinics |
Clinic Closures,
Reduced Capacity, and Clinic Transfers |
Most participants described clinics not being able to operate at full capacity • Mostly buprenorphine prescribers discussed clinic closures while methadone staff/clients discussed clinics reducing capacity |
Social Distancing | Instituted to prevent/reduce COVID-19 spread, some participants noted challenges of • Inability of clinics to enforce social distancing protocols • Long lines outside clinics which could increase visibility and stigma |